Advertisement

Bilirubin Metabolism and Hyperbilirubinemia

  • Yaron Ilan
  • Namita Roy Chowdhury
  • Jayanta Roy Chowdhury
Part of the Current Clinical Practice book series (CCP)

Abstract

As a physical sign and a biochemical marker, jaundice and hyperbilirubinemia are among the most frequently used “liver function tests.” The clinical significance of jaundice varies according to the underlying disease. Knowledge of the pathophysiology of bilirubin metabolism is required for its interpretation. Acquired causes of hyperbilirubinemia, which usually indicate liver disease or biliary obstruction, need to be differentiated from inborn errors of bilirubin metabolism. In acute hepatitis, jaundice is common and usually transient, whereas in alcoholic hepatitis and alcoholic or nonalcoholic liver cirrhosis, jaundice has a dismal prognosis (1). In the intensive care unit, in septic or multitrauma patients, it is associated with a higher mortality rate. In primary biliary cirrhosis, it is a major prognostic indicator predicting survival (1). Impairment of bile flow due to obstruction of the intrahepatic or extrahepatic biliary tract leads to accumulation of conjugated bilirubin in the blood and jaundice, and is an indication for surgical or endoscopic relief of the obstruction.

Keywords

Serum Bilirubin Level Bile Pigment Unconjugated Bilirubin Unconjugated Hyperbilirubinemia Bilirubin Conjugation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Roy Chowdhury J, Jansen PLM. Metabolism of bilirubin. In: Zakim D, Boyer TD, eds. Hepatology: a Textbook of Liver Disease. 3rd ed. WB Saunders, Philadelphia, 1996, pp. 323–347.Google Scholar
  2. 2.
    Roy Chowdhury J, Roy Chowdhury N, Arias IM. Hereditary jaundice and disorders of bilirubin metabolism. In: Sciver CR, Boudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. McGraw Hill, New York, 1995; pp. 2161–2208.Google Scholar
  3. 3.
    Roy Chowdhury J, Roy Chowdhury N, Arias IM. Heme and bile pigment metabolism. In: Arias IM, Jakoby WB, Schachter D, Shafritz DA, eds. The Liver: Biology and Pathobiology. 3rd ed. Raven, New York, 1994, pp. 505–527.Google Scholar
  4. 4.
    Bissel DM. Heme catabolism and bilirubin formation. In: Ostrow JD, ed. Bile Pigments and Jaundice. Marcel Dekker, New York, 1986; pp. 133–156.Google Scholar
  5. 5.
    Lightner D. Structure, photochemistry and organic chemistry of bilirubin. In: Heirwegh KPM, Brown S, ed. Bilirubin, vol. I. CRC, Boca Raton, 1982; pp. 1–58.Google Scholar
  6. 6.
    Brodersen R. Aqueous solubility, albumin-binding and tissue distribution of bilirubin. In: Ostrow JD, ed. Bile Pigments and Jaundice. Marcel Dekker, New York, 1986; pp. 157–181.Google Scholar
  7. 7.
    Weiss JS, Gautam A, Lauff JJ. The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia. New Engl J Med 1983;309:147–150.PubMedCrossRefGoogle Scholar
  8. 8.
    Sorrentino D, Berk PD. Mechanistic aspects of hepatic bilirubin uptake. Sem Liver Dis 1988;8:119–136.CrossRefGoogle Scholar
  9. 9.
    Roy Chowdhury J, Roy Chowdhury N, Falany CW, Tephly TW, Arias IM. Isolation and characterization of multiple forms of rat liver UDP-glucuronate glucuronosyltransferase. Biochem J 1986;233:827–837.PubMedGoogle Scholar
  10. 10.
    Boyer JL. Bile secretion-models, mechanisms and malfunctions. A perspective on the development of modern cellular and molecular concepts of bile secretion and cholestasis. J Gastroenterol 1996;31:475.PubMedCrossRefGoogle Scholar
  11. 11.
    Wolpert E, Pascasio FM, Wolkoff AW, Arias IM. Abnormal sulfobromophthalein metabolism in Rotor’s syndrom and obligate heterozygotes. N Eng J Med 1997;296:1099.CrossRefGoogle Scholar
  12. 12.
    Reichen J, Simon FR. Cholestasis. In: Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter D, Shafritz DA, eds. The Liver: Biology and Patholphysiology. Raven, New York, 1994; 1291–1326.Google Scholar
  13. 13.
    Billing BH. Intestinal and renal handling of bilirubin including enterohepatic circulation. In: Ostrow JD, ed. Bile Pigments and Jaundice. Marcel Dekker, New York, 1986; pp. 255–269.Google Scholar
  14. 14.
    Arthur LJH, Bevan BR, Holton JB. Neonatal hyperbilirubinemia and breast feeding. Dev Med Child Neurol 1966;8:279.PubMedCrossRefGoogle Scholar
  15. 15.
    Harding JB, Peeples MO. Serum bilirubin levels in newborn infants. distributions and associations with neurological abnormalities during the first year of life. Johns Hopkins Med J 1971; 128:265.Google Scholar
  16. 16.
    Roy Chowdhury J, Roy Chowdhury N. Unveiling the mysteries of inherited disorders of bilirubin glucuronidation. Gastroenterology 1993;105:288–293.Google Scholar
  17. 17.
    Crigler JF, Najjar VA. Congenital familial non-hemolytic jaundice with kernicterus. Pediatrics 1952; 10:169.PubMedGoogle Scholar
  18. 18.
    Wolkoff AW, Roy Chowdhury J. Crigler-Najjar syndrome (Type 1) in an adult male. Gastroenterology 1979;76:840–848.PubMedGoogle Scholar
  19. 19.
    Ritter J., Yeatman MT, Ferreira P, Owens IS. Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler Najjar type 1 patient. J Clin Invest 1992;90:150–155.PubMedCrossRefGoogle Scholar
  20. 20.
    Bosma PJ, Roy Chowdhury N, Goldhoorn BG, Hofker MH, Oude Elferink RPJ, Jansen PLM, Roy Chowdhury J. Sequence of exons and the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, Type I. Hepatology 1992;15:941.Google Scholar
  21. 21.
    Bosma PJ, Roy Chowdhury J, Huang TJ, Lahiri P, Oude Elferink RPJ, Van es HHG, Lederstein M, Whitington PF, Jansen PLM, Roy Chowdhury N. Mechanism of inherited deficiencies of multiple UDP-glucuronosyl-transferase isoforms in two patients with Crigler-Najjar syndrome, Type I. FASEB J 1992;6:2859.PubMedGoogle Scholar
  22. 22.
    Bosma PJ, Seppen J, Goldhoorn B, Bakker C, Oude Elferink RPJ, Roy Chowdhury J, Roy Chowdhury N, Jansen PLM. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 1994;269:17960.PubMedGoogle Scholar
  23. 23.
    Kaufman SS, Wood RP, Shaw BW, et. al. Orthotopic liver transplantation for type I Crigler-Najjar syndrome. Hepatology 1986;6:1259.PubMedCrossRefGoogle Scholar
  24. 24.
    Demetriou AA, Levenson SM, Whiting J, Feldman D, Moscioni AD, Kram M, Roy Chowdhury N, Roy Chowdhury J. Replacement of hepatic functions in rats by transplantation of microcarrier-attached hepatocytes. Science 1986;233:1190–1192.PubMedCrossRefGoogle Scholar
  25. 25.
    Arias IM, Gartner LM, Cohen M, Benezzer J, Levi AJ. Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency: clinical, biochemical, pharmacologic, and genetic evidence for heterogeneity. Am J Med 1969;47:395.PubMedCrossRefGoogle Scholar
  26. 26.
    Jansen PLM, Bosma PJ, Roy Chowdhury J. Molecular biology of bilirubin metabolism. Prog Liver Dis 1995;13:125–150.PubMedGoogle Scholar
  27. 27.
    Roy Chowdhury J, Arias IM. Disorders of bilirubin conjugation. In: Ostrow JD, ed. Bile Pigments and Jaundice. Marcel Dekker, New York, 1986; pp. 317–332.Google Scholar
  28. 28.
    Gilberts A, Lereboullet P. La cholemie simple familiale. Sem Med 1901;21:241.Google Scholar
  29. 29.
    Bosma PJ, Roy Chowdhury J, Bakker C. A sequence abnormality in the promoter region results in reduced expression of bilirubin-UDP-glucuronosyltransferase-1 in Gilbert’s syndrome. N Engl J Med 1995; 1171–1175.Google Scholar
  30. 30.
    Summerskill WJH. The syndrome of benign recurrent cholestasis. Am J Med 1965;38:298.PubMedCrossRefGoogle Scholar
  31. 31.
    Dubin IN, Johnson FB. Chronic idiopathic jaundice with unidentified pigment in liver cells: a new clinocopathologic entity with a report of 12 cases. Medicine (Baltimore) 1954;33:155.Google Scholar
  32. 32.
    Kondo T, Kuchiba K, Shimizu Y. Coproporphyrin isomers in Dubin-Johnson syndrome. Gastroenterology 1976;70:1117–1120.PubMedGoogle Scholar
  33. 33.
    Wolkoff AW. Inherited disorders manifested by conjugated hyperbilirubinemia. Sem Liver Dis 1983;3:65–72.CrossRefGoogle Scholar
  34. 34.
    Wolkoff AW, Wolpert E, Pascasio FN. Rotor’s syndrome, a distinct inheritable pathophysiological entity. Am J Med 1976;60:173–179.PubMedCrossRefGoogle Scholar
  35. 35.
    Rotor AB, Manahan L, Florentin A. Famillial nonhemolytic jaundice with direct van den Bergh reaction. Acta Med Phi. 1948;5:37.Google Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Yaron Ilan
  • Namita Roy Chowdhury
  • Jayanta Roy Chowdhury

There are no affiliations available

Personalised recommendations